Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.

Buisman FE, Galjart B, van der Stok EP, Kemeny NE, Balachandran VP, Boerner T, Cercek A, Grünhagen DJ, Jarnagin WR, Kingham TP, Verhoef C, Koerkamp BG, D'Angelica MI.

HPB (Oxford). 2019 Dec 27. pii: S1365-182X(19)33212-5. doi: 10.1016/j.hpb.2019.11.013. [Epub ahead of print]

PMID:
31889627
2.

PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis.

Yamaguchi N, Weinberg EM, Nguyen A, Liberti MV, Goodarzi H, Janjigian YY, Paty PB, Saltz LB, Kingham TP, Loo JM, de Stanchina E, Tavazoie SF.

Elife. 2019 Dec 16;8. pii: e52135. doi: 10.7554/eLife.52135.

3.

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ.

Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003703. [Epub ahead of print]

PMID:
31804389
4.

Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis.

Beard RE, Khan S, Troisi RI, Montalti R, Vanlander A, Fong Y, Kingham TP, Boerner T, Berber E, Kahramangil B, Buell JF, Martinie JB, Vrochides D, Shen C, Molinari M, Geller DA, Tsung A.

World J Surg. 2020 Mar;44(3):887-895. doi: 10.1007/s00268-019-05270-x.

PMID:
31748885
5.

Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry.

Sharma A, Alatise OI, Adisa AO, Arowolo OA, Olasehinde O, Famurewa OC, Omisore AD, Komolafe AO, Olaofe O, Katung AI, Ibikunle AD, Egberongbe AA, Olatoke SA, Agodirin SO, Adesiyun AO, Adeyeye A, Ibrahim K, Kolawole OA, Idris OL, Adejumobi MO, Ajayi AI, Olakanmi AO, Constable JC, Seier K, Gonen M, Brennan MF, Kingham TP.

J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25768. [Epub ahead of print]

PMID:
31742699
6.

Histopathological growth patterns and positive margins after resection of colorectal liver metastases.

Nierop PMH, Höppener DJ, van der Stok EP, Galjart B, Buisman FE, Balachandran VP, Jarnagin WR, Kingham TP, Allen PJ, Shia J, Vermeulen PB, Groot Koerkamp B, Grünhagen DJ, Verhoef C, D'Angelica MI.

HPB (Oxford). 2019 Nov 14. pii: S1365-182X(19)30755-5. doi: 10.1016/j.hpb.2019.10.015. [Epub ahead of print]

PMID:
31735649
7.

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer.

Datta J, Smith JJ, Chatila WK, McAuliffe JC, Kandoth C, Vakiani E, Frankel TL, Ganesh K, Wasserman I, Lipsyc-Sharf M, Guillem J, Nash GM, Paty PB, Weiser MR, Saltz LB, Berger MF, Jarnagin WR, Balachandran V, Kingham TP, Kemeny NE, Cercek A, Garcia-Aguilar J, Taylor BS, Viale A, Yaeger R, Solit DB, Schultz N, D'Angelica MI.

Clin Cancer Res. 2020 Mar 1;26(5):1077-1085. doi: 10.1158/1078-0432.CCR-19-2390. Epub 2019 Nov 12.

PMID:
31719050
8.

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA Jr, Kemeny NE, Jarnagin WR.

JAMA Oncol. 2019 Oct 31. doi: 10.1001/jamaoncol.2019.3718. [Epub ahead of print]

PMID:
31670750
9.

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.

Buisman FE, Grünhagen DJ, Homs MYV, Grootscholten C, Filipe WF, Kemeny NE, Cercek A, D'Angelica MI, Donswijk ML, van Doorn L, Emmering J, Jarnagin WR, Kingham TP, Klompenhouwer EG, Kok NFM, Kuiper MC, Moelker A, Prevoo W, Versleijen MWJ, Verhoef C, Kuhlmann KFD, Groot Koerkamp B.

Ann Surg Oncol. 2019 Dec;26(13):4599-4607. doi: 10.1245/s10434-019-07973-w. Epub 2019 Oct 22.

10.

Mapping Geospatial Access to Comprehensive Cancer Care in Nigeria.

Knapp GC, Tansley G, Olasehinde O, Alatise OI, Wuraola F, Olawole MO, Arije OO, Gali BM, Kingham TP.

J Glob Oncol. 2019 Oct;5:1-8. doi: 10.1200/JGO.19.00283.

11.

Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.

Narayan RR, Harris JW, Chou JF, Gönen M, Bao F, Shia J, Allen PJ, Balachandran VP, Drebin JA, Jarnagin WR, Kemeny NE, Kingham TP, D'Angelica MI.

Ann Surg Oncol. 2020 Jan;27(1):188-195. doi: 10.1245/s10434-019-07934-3. Epub 2019 Oct 15.

PMID:
31617122
12.

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.

Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassi C.

Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003579. [Epub ahead of print]

PMID:
31567347
13.

Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia.

Ntiamoah P, Monu NR, Abdulkareem FB, Adeniji KA, Obafunwa JO, Komolafe AO, Yates C, Kaninjing E, Carpten JD, Salhia B, Odedina FT, Edelweiss M, Kingham TP, Alatise OI.

J Glob Oncol. 2019 Sep;5:1-9. doi: 10.1200/JGO.19.00138.

14.

Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.

Ayabe RI, Narayan RR, Ruff SM, Wach MM, Lo W, Nierop PMH, Steinberg SM, Ripley RT, Davis JL, Koerkamp BG, D'Angelica MI, Kingham TP, Jarnagin WR, Hernandez JM.

HPB (Oxford). 2020 Jan;22(1):169-175. doi: 10.1016/j.hpb.2019.07.002. Epub 2019 Aug 22.

PMID:
31447392
15.

Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy.

Buisman FE, Galjart B, van der Stok EP, Balachandran VP, Boerner T, Drebin JA, Grünhagen DJ, Jarnagin WR, Kingham TP, Verhoef C, D'Angelica MI, Groot Koerkamp B.

World J Surg. 2020 Mar;44(3):876-886. doi: 10.1007/s00268-019-05121-9.

PMID:
31410513
16.

An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Knapp GC, Sharma A, Olopade B, Alatise OI, Olasehinde O, Arije OO, Castle PE, Kingham TP.

World J Surg. 2019 Nov;43(11):2674-2680. doi: 10.1007/s00268-019-05100-0.

PMID:
31407091
17.

CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.

Attiyeh MA, Chakraborty J, McIntyre CA, Kappagantula R, Chou Y, Askan G, Seier K, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ, Iacobuzio-Donahue CA, Simpson AL, Do RK.

Abdom Radiol (NY). 2019 Sep;44(9):3148-3157. doi: 10.1007/s00261-019-02112-1.

PMID:
31243486
18.

Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.

McIntyre CA, Pulvirenti A, Lawrence SA, Seier K, Gonen M, Balachandran VP, Kingham TP, DʼAngelica MI, Drebin JA, Jarnagin WR, Allen PJ.

Pancreas. 2019 Jul;48(6):832-836. doi: 10.1097/MPA.0000000000001342.

PMID:
31210665
19.

Is Colorectal Cancer Screening Appropriate in Nigeria?

Knapp GC, Alatise OI, Olasehinde OO, Adeyeye A, Ayandipo OO, Weiser MR, Kingham TP.

J Glob Oncol. 2019 Jun;5:1-10. doi: 10.1200/JGO.19.00035.

20.

Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study.

Deng L, Ismond K, Liu Z, Constable J, Wang H, Alatise OI, Weiser MR, Kingham TP, Chang D.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1283-1291. doi: 10.1158/1055-9965.EPI-18-1291. Epub 2019 May 31.

21.

Life Without a Breast: Exploring the Experiences of Young Nigerian Women After Mastectomy for Breast Cancer.

Olasehinde O, Arije O, Wuraola FO, Samson M, Olajide O, Alabi T, Arowolo O, Boutin-Foster C, Alatise OI, Kingham TP.

J Glob Oncol. 2019 May;5:1-6. doi: 10.1200/JGO.18.00248.

22.

Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution.

Creasy JM, Goldman DA, Gonen M, Dudeja V, O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP, Drebin JA, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR.

HPB (Oxford). 2019 Nov;21(11):1541-1551. doi: 10.1016/j.hpb.2019.03.370. Epub 2019 Apr 23.

PMID:
31027875
23.

ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases.

Narayan RR, Kingham TP.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):583-584. doi: 10.1245/s10434-019-07360-5. Epub 2019 Apr 15. No abstract available.

PMID:
30989499
24.

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B.

BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.

25.

Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.

Gholami S, Kemeny NE, Boucher TM, Gönen M, Cercek A, Kingham TP, Balachandran V, Allen P, DeMatteo R, Drebin J, Jarnagin W, D'Angelica M.

Ann Surg. 2019 Feb 19. doi: 10.1097/SLA.0000000000003248. [Epub ahead of print]

PMID:
30817353
26.

Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.

Narayan RR, Goldman DA, Gonen M, Reichel J, Huberman KH, Raj S, Viale A, Kemeny NE, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Jarnagin WR, Kingham TP.

Ann Surg Oncol. 2019 Jun;26(6):1824-1832. doi: 10.1245/s10434-019-07201-5. Epub 2019 Jan 31.

PMID:
30706231
27.

Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.

Pak LM, Gagnière J, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Miga MI, Simpson AL, Kingham TP.

J Gastrointest Surg. 2019 Apr;23(4):760-767. doi: 10.1007/s11605-019-04106-2. Epub 2019 Jan 24.

28.

Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study.

Lawrence SA, McIntyre CA, Pulvirenti A, Seier K, Chou Y, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Apr;228(4):595-601. doi: 10.1016/j.jamcollsurg.2018.12.018. Epub 2019 Jan 8.

PMID:
30630087
29.

Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities.

Olasehinde O, Alatise OI, Arowolo OA, Mango VL, Olajide OS, Omisore AD, Boutin-Foster C, Kingham TP.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12986. doi: 10.1111/ecc.12986. Epub 2019 Jan 6.

30.

Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR.

Cancer. 2019 Feb 15;125(4):575-585. doi: 10.1002/cncr.31850. Epub 2018 Nov 14.

31.

Minimally Invasive Staging Surgery for Cancer.

Cohen NA, Kingham TP.

Surg Oncol Clin N Am. 2019 Jan;28(1):61-77. doi: 10.1016/j.soc.2018.07.006. Epub 2018 Oct 23. Review.

PMID:
30414682
32.

Outcomes after Pancreatectomy with Routine Pasireotide Use.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Feb;228(2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. Epub 2018 Nov 7.

PMID:
30414453
33.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):395. doi: 10.1007/s00268-018-4845-x.

PMID:
30406321
34.

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D'Angelica MI, Berger MF, Hyman DM, Jarnagin W, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK.

Clin Cancer Res. 2019 Apr 1;25(7):2116-2126. doi: 10.1158/1078-0432.CCR-18-2293. Epub 2018 Oct 29.

35.

Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study.

Nota CL, Woo Y, Raoof M, Boerner T, Molenaar IQ, Choi GH, Kingham TP, Latorre K, Borel Rinkes IHM, Hagendoorn J, Fong Y.

Ann Surg Oncol. 2019 Feb;26(2):583-590. doi: 10.1245/s10434-018-6928-1. Epub 2018 Oct 17.

PMID:
30334196
36.

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection.

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA.

HPB (Oxford). 2019 Apr;21(4):434-443. doi: 10.1016/j.hpb.2018.08.010. Epub 2018 Oct 4.

PMID:
30293867
37.

Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.

Olasehinde O, Alatise O, Arowolo O, Adisa A, Wuraola F, Boutin-Foster C, Lawal O, Kingham T.

J Surg Oncol. 2018 Nov;118(6):861-866. doi: 10.1002/jso.25215. Epub 2018 Oct 7.

PMID:
30293243
38.

A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.

Gaspersz MP, Buettner S, Roos E, van Vugt JLA, Coelen RJS, Vugts J, Wiggers JK, Allen PJ, Besselink MG, Busch ORC, Belt EJ, D'Angelica MI, DeMatteo RP, de Jonge J, Kingham TP, Polak WG, Willemssen FEJA, van Gulik TM, Jarnagin WR, Ijzermans JNM, Groot Koerkamp B.

J Surg Oncol. 2018 Sep;118(3):469-476. doi: 10.1002/jso.25174. Epub 2018 Aug 21.

PMID:
30132904
39.

Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.

Attiyeh MA, Chakraborty J, Gazit L, Langdon-Embry L, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Do RK, Simpson AL.

HPB (Oxford). 2019 Feb;21(2):212-218. doi: 10.1016/j.hpb.2018.07.016. Epub 2018 Aug 7.

40.

Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes.

Gyedu A, Gaskill CE, Agbedinu K, Salazar DR, Kingham TP.

J Surg Oncol. 2018 Sep;118(3):581-587. doi: 10.1002/jso.25168. Epub 2018 Aug 10.

41.

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.

Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A.

PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.

42.

Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.

Gagnière J, Dupré A, Gholami SS, Pezet D, Boerner T, Gönen M, Kingham TP, Allen PJ, Balachandran VP, De Matteo RP, Drebin JA, Yaeger R, Kemeny NE, Jarnagin WR, D'Angelica MI.

Ann Surg. 2020 Jan;271(1):147-154. doi: 10.1097/SLA.0000000000002968.

PMID:
29995686
43.

Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):385-394. doi: 10.1007/s00268-018-4726-3. Erratum in: World J Surg. 2018 Nov 7;:.

44.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2019 Jan;29(1):458-467. doi: 10.1007/s00330-018-5542-8. Epub 2018 Jun 19.

45.

Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D'Angelica MI, Weiss MJ.

Br J Surg. 2018 Aug;105(9):1210-1220. doi: 10.1002/bjs.10838. Epub 2018 Apr 25.

PMID:
29691844
46.

A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.

Alatise OI, Ayandipo OO, Adeyeye A, Seier K, Komolafe AO, Bojuwoye MO, Afuwape OO, Zauber A, Omisore A, Olatoke S, Akere A, Famurewa O, Gonen M, Irabor DO, Kingham TP.

Cancer. 2018 Jul 1;124(13):2766-2773. doi: 10.1002/cncr.31399. Epub 2018 Apr 12.

47.

Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR.

J Am Coll Surg. 2018 Aug;227(2):238-246.e2. doi: 10.1016/j.jamcollsurg.2018.03.041. Epub 2018 Apr 6.

48.

Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2018 Jun;25(6):1752-1759. doi: 10.1245/s10434-018-6445-2. Epub 2018 Mar 27.

PMID:
29589164
49.

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Blumgart LH, Jarnagin WR, D'Angelica MI.

Surgery. 2018 Jun;163(6):1238-1244. doi: 10.1016/j.surg.2018.01.004. Epub 2018 Feb 15.

PMID:
29455841
50.

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.

Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK.

Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.

Supplemental Content

Loading ...
Support Center